GSBR-1290
GSBR-1290-02
Phase 2 small_molecule completed
Quick answer
GSBR-1290 for Overweight or Obesity is a Phase 2 program (small_molecule) at Structure Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Structure Therapeutics
- Indication
- Overweight or Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed